{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:35Z","timestamp":1786985435136,"version":"build-2736575974"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Chongqing Natural Science Foundation","doi-asserted-by":"publisher","award":["cstc2021jcyj-msxmX0423"],"award-info":[{"award-number":["cstc2021jcyj-msxmX0423"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2025ZNSFSC0546"],"award-info":[{"award-number":["2025ZNSFSC0546"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020207","name":"Health and Family Planning Commission of Sichuan Province","doi-asserted-by":"publisher","award":["24QNMP010"],"award-info":[{"award-number":["24QNMP010"]}],"id":[{"id":"10.13039\/501100020207","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bmcl.2025.130330","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T17:18:09Z","timestamp":1752599889000},"page":"130330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Recent advances and perspectives in therapeutics for mpox"],"prefix":"10.1016","volume":"128","author":[{"given":"Yaru","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingnan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongke","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bmcl.2025.130330_bb0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/v15010103","article-title":"Smallpox, Monkeypox and other human Orthopoxvirus infections","volume":"15","author":"Shchelkunova","year":"2022","journal-title":"Viruses"},{"issue":"10370","key":"10.1016\/j.bmcl.2025.130330_bb0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(22)02075-X","article-title":"Monkeypox","volume":"401","author":"Mitj\u00e0","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130330_bb0015","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1080\/22221751.2022.2132882","article-title":"Comprehensive literature review of monkeypox","volume":"11","author":"Hatmal","year":"2022","journal-title":"Emerg Microbes Infect"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130330_bb0020","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1053\/j.spid.2004.09.001","article-title":"Monkeypox: a review of the history and emergence in the Western hemisphere","volume":"15","author":"Ligon","year":"2004","journal-title":"Semin Pediatr Infect Dis"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130330_bb0025","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1699-0463.1959.tb00328.x","article-title":"A pox-like disease in Cynomolgus monkeys","volume":"46","author":"von Magnus","year":"1959","journal-title":"Acta Pathologica Microbiologica Scandinavica"},{"key":"10.1016\/j.bmcl.2025.130330_bb0030","article-title":"Monkeypox: a contemporary review for healthcare professionals. Open forum","volume":"9(7):ofac310","author":"Titanji","year":"2022","journal-title":"Infect Dis"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130330_bb0035","first-page":"283","article-title":"Monkeypox disease: An emerging public health concern in the shadow of COVID-19 pandemic: An update","volume":"7","author":"Hasan","year":"2022","journal-title":"Trop Med Infect Dis"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130330_bb0040","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1086\/498155","article-title":"Reemergence of monkeypox: prevalence, diagnostics, and countermeasures","volume":"41","author":"Nalca","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmcl.2025.130330_bb0045","doi-asserted-by":"crossref","first-page":"1174223","DOI":"10.3389\/fimmu.2023.1174223","article-title":"Global transmission of monkeypox virus-a potential threat under the COVID-19 pandemic","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130330_bb0050","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries - April-June 2022","volume":"387","author":"Thornhill","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130330_bb0055","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1007\/s11030-023-10767-8","article-title":"Exploring Monkeypox: prospects for therapeutics through computational-aided drug discovery","volume":"28","author":"Grajales","year":"2024","journal-title":"Mol Divers"},{"key":"10.1016\/j.bmcl.2025.130330_bb0060","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268823000791","article-title":"Monkeypox: a review of epidemiological modelling studies and how modelling has led to mechanistic insight","volume":"151","author":"Banuet-Martinez","year":"2023","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.bmcl.2025.130330_bb0065","article-title":"Monkeypox 2024 outbreak: fifty essential questions and answers","volume":"4","author":"Cabanillas","year":"2024","journal-title":"Allergy Published online November"},{"key":"10.1016\/j.bmcl.2025.130330_bb0070","unstructured":"2022\u201324 Mpox (Monkeypox) Outbreak: Global Trends. Accessed December 16, 2024. https:\/\/worldhealthorg.shinyapps.io\/mpx_global\/#8_Disclaimers."},{"issue":"1","key":"10.1016\/j.bmcl.2025.130330_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/br.37.1.1-18.1973","article-title":"Monkeypox virus","volume":"37","author":"Cho","year":"1973","journal-title":"Bacteriol Rev"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130330_bb0080","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.virs.2022.07.006","article-title":"Monkeypox virus: a re-emergent threat to humans","volume":"37","author":"Gong","year":"2022","journal-title":"Virol Sin"},{"key":"10.1016\/j.bmcl.2025.130330_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104424","article-title":"The land-scape of immune response to monkeypox virus","volume":"87","author":"Li","year":"2023","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130330_bb0090","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bsheal.2022.09.004","article-title":"The current emergence of monkeypox: the recurrence of another smallpox?","volume":"4","author":"Lu","year":"2022","journal-title":"Biosaf Health"},{"key":"10.1016\/j.bmcl.2025.130330_bb0095","doi-asserted-by":"crossref","first-page":"1088471","DOI":"10.3389\/fcimb.2022.1088471","article-title":"The monkeypox diagnosis, treatments and prevention: a review","volume":"12","author":"Khattak","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130330_bb0100","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jiph.2023.02.003","article-title":"Monkeypox (mpox) virus: classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis","volume":"16","author":"Karagoz","year":"2023","journal-title":"J Infect Public Health."},{"issue":"7","key":"10.1016\/j.bmcl.2025.130330_bb0105","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.cell.2019.11.023","article-title":"Structural basis of poxvirus transcription: transcribing and capping vaccinia complexes","volume":"179","author":"Hillen","year":"2019","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130330_bb0110","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1006\/viro.2002.1446","article-title":"Analysis of the monkeypox virus genome","volume":"297","author":"Shchelkunov","year":"2002","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130330_bb0115","article-title":"Monkeypox: a comprehensive review of transmission, pathogenesis, and manifestation","volume":"14","author":"Kaler","year":"2022","journal-title":"Cureus"},{"issue":"18","key":"10.1016\/j.bmcl.2025.130330_bb0120","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.3390\/molecules27185898","article-title":"Kinetic and structural aspects of glycosaminoglycan-Monkeypox virus protein A29 interactions using surface Plasmon resonance","volume":"27","author":"Shi","year":"2022","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130330_bb0125","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1128\/JVI.73.10.8750-8761.1999","article-title":"Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells","volume":"73","author":"Hsiao","year":"1999","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130330_bb0130","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1128\/JVI.72.2.1577-1585.1998","article-title":"A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate","volume":"72","author":"Chung","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.bmcl.2025.130330_bb0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.semcdb.2016.07.015","article-title":"Membrane fusion during poxvirus entry","volume":"60","author":"Moss","year":"2016","journal-title":"Semin Cell Dev Biol"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130330_bb0140","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/s12276-021-00691-y","article-title":"Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing","volume":"53","author":"Chathuranga","year":"2021","journal-title":"Exp Mol Med"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130330_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/v15122301","article-title":"Monkeypox virus immune evasion and eye manifestation: beyond eyelid implications","volume":"15","author":"Lucena-Neto","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.bmcl.2025.130330_bb0150","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1146\/annurev.immunol.21.120601.141049","article-title":"Poxviruses and immune evasion","volume":"21","author":"Seet","year":"2003","journal-title":"Annu Rev Immunol"},{"issue":"6627","key":"10.1016\/j.bmcl.2025.130330_bb0155","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.ade6360","article-title":"Structure of monkeypox virus DNA polymerase holoenzyme","volume":"379","author":"Peng","year":"2023","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130330_bb0160","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41597-023-02149-4","article-title":"In-depth temporal transcriptome profiling of Monkeypox and host cells using Nanopore sequencing","volume":"10","author":"Kakuk","year":"2023","journal-title":"Sci Data"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130330_bb0165","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.virusres.2004.08.015","article-title":"The exit of vaccinia virus from infected cells","volume":"106","author":"Smith","year":"2004","journal-title":"Virus Res"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130330_bb0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.antiviral.2012.02.012","article-title":"Orthopoxvirus targets for the development of new antiviral agents","volume":"94","author":"Prichard","year":"2012","journal-title":"Antivir Res"},{"key":"10.1016\/j.bmcl.2025.130330_bb0175","doi-asserted-by":"crossref","first-page":"1360586","DOI":"10.3389\/fcimb.2024.1360586","article-title":"A comprehensive review of monkeypox virus and mpox characteristics","volume":"14","author":"Alakunle","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"issue":"Pt 12","key":"10.1016\/j.bmcl.2025.130330_bb0180","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"J Gen Virol."},{"issue":"4","key":"10.1016\/j.bmcl.2025.130330_bb0185","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.imj.2023.11.001","article-title":"Monkeypox virus (MPXV): a brief account of global spread, epidemiology, virology, clinical features, pathogenesis, and therapeutic interventions","volume":"2","author":"Islam","year":"2023","journal-title":"Infect Med (Beijing)"},{"issue":"19","key":"10.1016\/j.bmcl.2025.130330_bb0190","doi-asserted-by":"crossref","first-page":"11570","DOI":"10.3390\/ijms231911570","article-title":"Identification of Diosmin and Flavin adenine dinucleotide as repurposing treatments for Monkeypox virus: a computational study","volume":"23","author":"Lam","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"15","key":"10.1016\/j.bmcl.2025.130330_bb0195","doi-asserted-by":"crossref","first-page":"8100","DOI":"10.1080\/07391102.2023.2245042","article-title":"Supervised screening of Tecovirimat-like compounds as potential inhibitors for the monkeypox virus E8L protein","volume":"42","author":"Mehmood","year":"2023","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmcl.2025.130330_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2023.103656","article-title":"Natural photosensitizers potentiate the targeted antimicrobial photodynamic therapy as the Monkeypox virus entry inhibitors: An in silico approach","volume":"43","author":"Pourhajibagher","year":"2023","journal-title":"Photodiagn Photodyn Ther"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130330_bb0205","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s13337-024-00900-y","article-title":"Structure-based drug designing for potential antiviral activity of selected natural product against monkeypox (mpox) virus and its host targets","volume":"35","author":"Maurya","year":"2024","journal-title":"Virusdisease"},{"key":"10.1016\/j.bmcl.2025.130330_bb0210","doi-asserted-by":"crossref","first-page":"1073419","DOI":"10.3389\/fmicb.2022.1073419","article-title":"Targeting envelope proteins of poxviruses to repurpose phytochemicals against monkeypox: An in silico investigation","volume":"13","author":"Gulati","year":"2022","journal-title":"Front Microbiol"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130330_bb0215","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3390\/ph15091129","article-title":"Fludarabine, a potential DNA-dependent RNA polymerase inhibitor, as a prospective drug against Monkeypox virus: a computational approach","volume":"15","author":"Altayb","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130330_bb0220","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s13337-024-00869-8","article-title":"Repurposing FDA approved drugs against monkeypox virus DNA dependent RNA polymerase: virtual screening, normal mode analysis and molecular dynamics simulation studies","volume":"35","author":"Khan","year":"2024","journal-title":"Virusdisease"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130330_bb0225","doi-asserted-by":"crossref","first-page":"14570","DOI":"10.1038\/s41598-023-41820-z","article-title":"A multi-targeted computational drug discovery approach for repurposing tetracyclines against monkeypox virus","volume":"13","author":"Alandijany","year":"2023","journal-title":"Sci Rep"},{"issue":"Pt 8","key":"10.1016\/j.bmcl.2025.130330_bb0230","article-title":"Crystal structure of mRNA cap (guanine-N7) methyltransferase E12 subunit from monkeypox virus and discovery of its inhibitors","volume":"253","author":"Wang","year":"2023","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130330_bb0235","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1038\/s41467-023-38019-1","article-title":"Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase","volume":"14","author":"Silhan","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2025.130330_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105714","article-title":"Inhibitors of mpox VP39 2\u2019-O methyltransferase efficiently inhibit the monkeypox virus","volume":"218","author":"Zgarbov\u00e1","year":"2023","journal-title":"Antivir Res"},{"key":"10.1016\/j.bmcl.2025.130330_bb0245","article-title":"Targeting Monkeypox virus methyltransferase: virtual screening of natural compounds from middle-eastern medicinal plants","author":"Hashim","year":"2024","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.bmcl.2025.130330_bb0250","first-page":"1","article-title":"Natural compounds inhibit Monkeypox virus methyltransferase VP39 in silico studies","author":"Thai","year":"2024","journal-title":"J Biomol Struct Dyn"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130330_bb0255","article-title":"Molecular docking of seaweed-derived drug Fucoxanthin against the Monkeypox virus","volume":"16","author":"Nikitha","year":"2024","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130330_bb0260","first-page":"1617","article-title":"Evaluating the binding potential and stability of drug-like compounds with the monkeypox virus VP39 protein using molecular dynamics simulations and free energy analysis","volume":"17","author":"Hassan","year":"2024","journal-title":"Pharm (Basel Switz)"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130330_bb0265","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s40203-025-00310-y","article-title":"From phytomedicine to conventional drug research, to look for new drug molecule against monkey pox virus; a molecular docking, virtual screening and ADME analysis","volume":"13","author":"Goswami","year":"2025","journal-title":"In Silico Pharmacol"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130330_bb0270","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3390\/molecules28031444","article-title":"Potential inhibitors of Monkeypox virus revealed by molecular modeling approach to viral DNA topoisomerase I","volume":"28","author":"Hu","year":"2023","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130330_bb0275","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1007\/s00210-023-02769-y","article-title":"Potential use of cidofovir, brincidofovir, and tecovirimat drugs in fighting monkeypox infection: recent trends and advancements","volume":"397","author":"Rani","year":"2024","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1016\/j.bmcl.2025.130330_bb0280","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ijbiomac.2022.12.252","article-title":"Identification of probable inhibitors for the DNA polymerase of the Monkeypox virus through the virtual screening approach","volume":"229","author":"Kumari","year":"2023","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130330_bb0285","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s12088-024-01244-3","article-title":"Inhibition of Monkeypox virus DNA polymerase using Moringa oleifera phytochemicals: computational studies of drug-likeness, molecular docking, molecular dynamics simulation and density functional theory","volume":"64","author":"Yousaf","year":"2024","journal-title":"Indian J Microbiol"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130330_bb0290","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40203-025-00307-7","article-title":"Repurposing doxycycline for the inhibition of monkeypox virus DNA polymerase: a comprehensive computational study","volume":"13","author":"Yousaf","year":"2025","journal-title":"In Silico Pharmacol."},{"issue":"23","key":"10.1016\/j.bmcl.2025.130330_bb0295","doi-asserted-by":"crossref","first-page":"13247","DOI":"10.1080\/07391102.2023.2274982","article-title":"Molecular level investigation for identifying potential inhibitors against thymidylate kinase of monkeypox through in silico approaches","volume":"42","author":"Koirala","year":"2024","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmcl.2025.130330_bb0300","doi-asserted-by":"crossref","first-page":"1159389","DOI":"10.3389\/fcimb.2023.1159389","article-title":"Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus","volume":"13","author":"Ajmal","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"20","key":"10.1016\/j.bmcl.2025.130330_bb0305","doi-asserted-by":"crossref","first-page":"10678","DOI":"10.1080\/07391102.2023.2188428","article-title":"Pharmacophore modelling-based drug repurposing approaches for monkeypox therapeutics","volume":"41","author":"Alagarsamy","year":"2023","journal-title":"J Biomol Struct Dyn"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130330_bb0310","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s11030-023-10692-w","article-title":"Identification of novel potential inhibitors of monkeypox virus thymidine kinase using molecular docking, molecular dynamics simulation and MM\/PBSA methods","volume":"28","author":"Abdizadeh","year":"2024","journal-title":"Mol Divers"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130330_bb0315","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1007\/s11030-023-10764-x","article-title":"Identification of the myxobacterial secondary metabolites Aurachin a and Soraphinol a as promising inhibitors of thymidylate kinase of the Monkeypox virus","volume":"28","author":"Ali","year":"2024","journal-title":"Mol Divers"},{"key":"10.1016\/j.bmcl.2025.130330_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.106797","article-title":"Structure-based design of promising natural products to inhibit thymidylate kinase from Monkeypox virus and validation using free energy calculations","volume":"158","author":"Khan","year":"2023","journal-title":"Comput Biol Med"},{"issue":"23","key":"10.1016\/j.bmcl.2025.130330_bb0325","doi-asserted-by":"crossref","first-page":"13679","DOI":"10.1080\/07391102.2023.2179547","article-title":"Novel phytochemical inhibitors targeting monkeypox virus thymidine and serine\/threonine kinase: integrating computational modeling and molecular dynamics simulation","volume":"41","author":"Patel","year":"2023","journal-title":"J Biomol Struct Dyn"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130330_bb0330","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s11030-023-10705-8","article-title":"Cheminformatics and machine learning approaches for repurposing anti-viral compounds against monkeypox virus thymidylate kinase","volume":"28","author":"Rabaan","year":"2024","journal-title":"Mol Divers"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130330_bb0335","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s11030-022-10550-1","article-title":"In silico identification of potential inhibitors of vital monkeypox virus proteins from FDA approved drugs","volume":"27","author":"Sahoo","year":"2023","journal-title":"Mol Divers"},{"key":"10.1016\/j.bmcl.2025.130330_bb0340","doi-asserted-by":"crossref","unstructured":"Mishra SK, Chandra A, Mitra N, et al. Exploring the dynamics of asparagus racemosus phytochemicals as dual target inhibitors of monkeypox virus Curr Med Chem Published online February 7, 2025. doi:https:\/\/doi.org\/10.2174\/0109298673361923250101072831.","DOI":"10.2174\/0109298673361923250101072831"},{"key":"10.1016\/j.bmcl.2025.130330_bb0345","doi-asserted-by":"crossref","unstructured":"Rabaan AA, Alshahrani FS, Garout M, et al. Repositioning of anti-infective compounds against monkeypox virus core cysteine proteinase: a molecular dynamics study Mol Divers Published online April 23, 2024. doi:https:\/\/doi.org\/10.1007\/s11030-023-10802-8.","DOI":"10.1007\/s11030-023-10802-8"},{"key":"10.1016\/j.bmcl.2025.130330_bb0350","article-title":"Repurposing anti-dengue compounds against Monkeypox virus targeting Core cysteine protease","volume":"11(7):2025","author":"Imran","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130330_bb0355","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/v15010251","article-title":"Exploration of Microbially derived natural compounds against Monkeypox virus as viral Core cysteine proteinase inhibitors","volume":"15","author":"Dubey","year":"2023","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130330_bb0360","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.3390\/ijms24087119","article-title":"Targeting the I7L protease: a rational Design for Anti-Monkeypox Drugs?","volume":"24","author":"Dodaro","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2025.130330_bb0365","doi-asserted-by":"crossref","first-page":"fnaf008","DOI":"10.1093\/femsle\/fnaf008","article-title":"In vitro enzyme characterization and several inhibitors for monkeypox virus core protease I7L","volume":"372","author":"Wei","year":"2025","journal-title":"FEMS Microbiol Lett"},{"issue":"16","key":"10.1016\/j.bmcl.2025.130330_bb0370","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.3390\/molecules27165277","article-title":"In silico repurposed drugs against Monkeypox virus","volume":"27","author":"Lam","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130330_bb0375","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3390\/biomedicines11041106","article-title":"VP37 protein inhibitors for mpox treatment: highlights on recent advances, patent literature, and future directions","volume":"11","author":"Hudu","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130330_bb0380","doi-asserted-by":"crossref","first-page":"2373309","DOI":"10.1080\/22221751.2024.2373309","article-title":"Identification of the VP37 pocket of monkeypox virus as a promising target for pan-orthopoxvirus inhibitors through virtual screening and antiviral assays","volume":"13","author":"Huo","year":"2024","journal-title":"Emerg Microbes Infect"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130330_bb0385","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3390\/v15020570","article-title":"Fragment-based approaches identified Tecovirimat-competitive novel drug candidate for targeting the F13 protein of the Monkeypox virus","volume":"15","author":"Ali","year":"2023","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130330_bb0390","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s13258-023-01449-8","article-title":"Repurposing existing drugs for monkeypox: applications of virtual screening methods","volume":"45","author":"Li","year":"2023","journal-title":"Genes Genom"},{"key":"10.1016\/j.bmcl.2025.130330_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107116","article-title":"Exploiting the potential of natural polyphenols as antivirals against monkeypox envelope protein F13 using machine learning and all-atoms MD simulations","volume":"162","author":"Rout","year":"2023","journal-title":"Comput Biol Med"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130330_bb0400","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jiph.2023.03.007","article-title":"AI-driven drug repurposing and binding pose meta dynamics identifies novel targets for monkeypox virus","volume":"16","author":"Patel","year":"2023","journal-title":"J Infect Public Health"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130330_bb0405","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1016\/j.asjsur.2023.08.066","article-title":"Potential antiviral drugs against the human monkeypox virus: in silico perspective","volume":"47","author":"Ruan","year":"2024","journal-title":"Asian J Surg"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130330_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0299342","article-title":"Antivirals for monkeypox virus: proposing an effective machine\/deep learning framework","volume":"19","author":"Hashemi","year":"2024","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130330_bb0415","first-page":"154","article-title":"Drug screening against F13 protein, the target of tecovirimat, as potential therapies for monkeypox virus","volume":"86","author":"Chen","year":"2023","journal-title":"J Inf Secur"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130330_bb0420","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04745-22","article-title":"Identification of in vitro inhibitors of monkeypox replication","volume":"11","author":"Chiem","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130330_bb0425","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70240","article-title":"Inhibition of polo-like kinase 1 dampens the replication of vaccinia virus in mammalian cells","volume":"97","author":"Zhu","year":"2025","journal-title":"J Med Virol"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130330_bb0430","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.bsheal.2024.11.002","article-title":"Narciclasine inhibits vaccinia virus infection by activating the RhoA signaling pathway","volume":"6","author":"Xu","year":"2024","journal-title":"Biosaf Health."},{"key":"10.1016\/j.bmcl.2025.130330_bb0435","doi-asserted-by":"crossref","first-page":"1328308","DOI":"10.3389\/fphar.2023.1328308","article-title":"Exploring the natural products chemical space to abrogate the F3L-dsRNA interface of monkeypox virus to enhance the immune responses using molecular screening and free energy calculations","volume":"14","author":"Suleman","year":"2024","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130330_bb0440","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/JS9.0000000000000010","article-title":"Repurposing cholesterol lowering drugs in the treatment and management of monkeypox","volume":"109","author":"Sekaran","year":"2023","journal-title":"Int J Surg"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130330_bb0445","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jacl.2022.08.003","article-title":"Monkeypox is a global public health emergency: the role of repurposing cholesterol lowering drugs not to be forgotten","volume":"16","author":"Vuorio","year":"2022","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130330_bb0450","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/bioengineering10010011","article-title":"Chain-engineering-based De novo drug design against MPXVgp169 virulent protein of Monkeypox virus: a molecular modification approach","volume":"10","author":"Naveed","year":"2022","journal-title":"Bioengineering (Basel)"},{"key":"10.1016\/j.bmcl.2025.130330_bb0455","doi-asserted-by":"crossref","DOI":"10.1177\/11779322221141164","article-title":"Drug and anti-viral peptide design to inhibit the Monkeypox virus by restricting A36R protein","volume":"16","author":"Miah","year":"2022","journal-title":"Bioinform Biol Insights"},{"issue":"11","key":"10.1016\/j.bmcl.2025.130330_bb0460","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202400895","article-title":"Network-based drug repurposing and genomic analysis to unveil potential therapeutics for Monkeypox virus","volume":"21","author":"Rabaan","year":"2024","journal-title":"Chem Biodivers"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130330_bb0465","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1128\/JVI.73.10.8750-8761.1999","article-title":"Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells","volume":"73","author":"Hsiao","year":"1999","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130330_bb0470","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41594-021-00655-w","article-title":"Structural basis of the complete poxvirus transcription initiation process","volume":"28","author":"Grimm","year":"2021","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130330_bb0475","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1128\/jvi.66.2.971-982.1992","article-title":"Identification and expression of rpo19, a vaccinia virus gene encoding a 19-kilodalton DNA-dependent RNA polymerase subunit","volume":"66","author":"Ahn","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.bmcl.2025.130330_bb0480","doi-asserted-by":"crossref","first-page":"1106247","DOI":"10.3389\/fmicb.2023.1106247","article-title":"Mechanisms of immune evasion of monkeypox virus","volume":"14","author":"Zandi","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmcl.2025.130330_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105663","article-title":"Structural basis for RNA-cap recognition and methylation by the mpox methyltransferase VP39","volume":"216","author":"Skvara","year":"2023","journal-title":"Antivir Res"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130330_bb0490","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0092-8674(00)81101-0","article-title":"The 1.85 a structure of vaccinia protein VP39: a bifunctional enzyme that participates in the modification of both mRNA ends","volume":"85","author":"Hodel","year":"1996","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130330_bb0495","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1128\/AAC.49.8.3153-3162.2005","article-title":"Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate","volume":"49","author":"Magee","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2025.130330_bb0500","doi-asserted-by":"crossref","first-page":"1149909","DOI":"10.3389\/fphar.2023.1149909","article-title":"Pharmacological treatment and vaccines in monkeypox virus: a narrative review and bibliometric analysis","volume":"14","author":"Shamim","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmcl.2025.130330_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105488","article-title":"A retrospective genomic characterisation of the 2022 mpox outbreak in Belgium, and in vitro assessment of three antiviral compounds","volume":"110","author":"Wawina-Bokalanga","year":"2024","journal-title":"EBioMedicine"},{"issue":"7077","key":"10.1016\/j.bmcl.2025.130330_bb0510","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nature04295","article-title":"Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection","volume":"439","author":"Stittelaar","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2025.130330_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2022.102417","article-title":"Hospitalisation for monkeypox in Milan, Italy","volume":"49","author":"Moschese","year":"2022","journal-title":"Travel Med Infect Dis"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130330_bb0520","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jaad.2022.10.043","article-title":"Human monkeypox outbreak: epidemiological data and therapeutic potential of topical cidofovir in a prospective cohort study","volume":"88","author":"Sobral-Costas","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130330_bb0525","doi-asserted-by":"crossref","first-page":"A84","DOI":"10.1016\/j.antiviral.2009.01.005","article-title":"Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art","volume":"82","author":"Hostetler","year":"2009","journal-title":"Antivir Res"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130330_bb0530","article-title":"Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model","volume":"6","author":"Hutson","year":"2021","journal-title":"Msphere"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130330_bb0535","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"Clinical features and management of human monkeypox: a retrospective observational study in the UK","volume":"22","author":"Adler","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130330_bb0540","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.2174\/0929867311320100006","article-title":"Thymidylate kinase: an old topic brings new perspectives","volume":"20","author":"Cui","year":"2013","journal-title":"Curr Med Chem"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130330_bb0545","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.3390\/v6103787","article-title":"From crescent to mature virion: vaccinia virus assembly and maturation","volume":"6","author":"Liu","year":"2014","journal-title":"Viruses"},{"issue":"20","key":"10.1016\/j.bmcl.2025.130330_bb0550","doi-asserted-by":"crossref","first-page":"11279","DOI":"10.1128\/JVI.77.20.11279-11283.2003","article-title":"Molecular dissection of the vaccinia virus I7L core protein proteinase","volume":"77","author":"Byrd","year":"2003","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130330_bb0555","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/med.21475","article-title":"Proteases and protease inhibitors in infectious diseases","volume":"38","author":"Agbowuro","year":"2018","journal-title":"Med Res Rev"},{"issue":"10\u221211","key":"10.1016\/j.bmcl.2025.130330_bb0560","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10822-007-9138-7","article-title":"Discovery of small molecule inhibitors of ubiquitin-like poxvirus proteinase I7L using homology modeling and covalent docking approaches","volume":"21","author":"Katritch","year":"2007","journal-title":"J Comput Aided Mol Des"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130330_bb0565","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0042-6822(92)90467-4","article-title":"Immature viral envelope formation is interrupted at the same stage by lac operator-mediated repression of the vaccinia virus D13L gene and by the drug rifampicin","volume":"187","author":"Zhang","year":"1992","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130330_bb0570","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.virol.2006.09.031","article-title":"Amino acid substitutions at multiple sites within the vaccinia virus D13 scaffold protein confer resistance to rifampicin","volume":"359","author":"Charity","year":"2007","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130330_bb0575","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1006\/viro.1993.1303","article-title":"Mutations in ORF D13L and other genetic loci alter the rifampicin phenotype of vaccinia virus","volume":"194","author":"McNulty-Kowalczyk","year":"1993","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130330_bb0580","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000322101","article-title":"Orthopox viruses: infections in humans","volume":"37","author":"Pauli","year":"2010","journal-title":"Transfus Med Hemother"},{"issue":"37","key":"10.1016\/j.bmcl.2025.130330_bb0585","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.15585\/mmwr.mm7137e1","article-title":"Clinical use of Tecovirimat (Tpoxx) for treatment of Monkeypox under an investigational new drug protocol - United States, may-august 2022","volume":"71","author":"O\u2019Laughlin","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130330_bb0590","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/cid\/ciac622","article-title":"Antivirals with activity against Mpox: a clinically oriented review","volume":"76","author":"Siegrist","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmcl.2025.130330_bb0595","doi-asserted-by":"crossref","unstructured":"Rao AK, Schulte J, Chen TH, et al. Monkeypox in a traveler returning from Nigeria - dallas, texas, july 2021. MMWR Morb Mortal Wkly Rep 2022;71(14):509\u2013516. doi:10.15585\/mmwr.mm7114a1.","DOI":"10.15585\/mmwr.mm7114a1"},{"key":"10.1016\/j.bmcl.2025.130330_bb0600","article-title":"Tecovirimat for the treatment of human monkeypox: an initial series from Massachusetts, United States. Open forum","volume":"9(8):ofac377","author":"Matias","year":"2022","journal-title":"Infect Dis."},{"issue":"9","key":"10.1016\/j.bmcl.2025.130330_bb0605","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1099\/vir.0.000216","article-title":"Using ICR and SCID mice as animal models for smallpox to assess antiviral drug efficacy","volume":"96","author":"Titova","year":"2015","journal-title":"J Gen Virol"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130330_bb0610","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1099\/jgv.0.000422","article-title":"New effective chemically synthesized anti-smallpox compound NIOCH-14","volume":"97","author":"Mazurkov","year":"2016","journal-title":"J Gen Virol."},{"issue":"2","key":"10.1016\/j.bmcl.2025.130330_bb0615","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10517-020-05034-x","article-title":"Estimation of absolute bioavailability of the chemical substance of the anti-smallpox preparation NIOCH-14 in mice","volume":"170","author":"Mazurkov","year":"2020","journal-title":"Bull Exp Biol Med"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130330_bb0620","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/v17010092","article-title":"Repurposing drugs for synergistic combination therapies to counteract monkeypox virus tecovirimat resistance","volume":"17","author":"Witwit","year":"2025","journal-title":"Viruses"},{"issue":"Supplement_2","key":"10.1016\/j.bmcl.2025.130330_bb0625","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiad516","article-title":"Variola virus and clade I Mpox virus differentially modulate cellular responses longitudinally in monocytes during infection","volume":"229","author":"Wahl","year":"2024","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130330_bb0630","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.3390\/ijms26062718","article-title":"Antiviral effects of Tecovirimat and cellular ultrastructural changes in human bronchial epithelial cell line following Monkeypox virus infection","volume":"26","author":"Falasca","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"Pt 2","key":"10.1016\/j.bmcl.2025.130330_bb0635","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1099\/vir.0.005108-0","article-title":"A prairie dog animal model of systemic orthopoxvirus disease using west african and Congo basin strains of monkeypox virus","volume":"90","author":"Hutson","year":"2009","journal-title":"J Gen Virol."},{"issue":"8","key":"10.1016\/j.bmcl.2025.130330_bb0640","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1128\/JVI.02012-09","article-title":"A mouse model of lethal infection for evaluating prophylactics and therapeutics against monkeypox virus","volume":"84","author":"Stabenow","year":"2010","journal-title":"J Virol"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25002392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25002392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:18:41Z","timestamp":1776917921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25002392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":128,"alternative-id":["S0960894X25002392"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130330","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances and perspectives in therapeutics for mpox","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130330"}}